Firefly Neuroscience, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.4% | -36.8% | +15,763.4% | -98.3% | +60.6% | -18.9% | +595.3% | +29.8% | +6.2% | +17.7% | +6.0% | – | |
| – | – | – | -3.8% | +20.6% | -96.0% | -100.0% | – | +868.0% | -5.0% | +14.8% | -1.1% | – | |
| – | -17.4% | -36.8% | +5,589.1% | -310.8% | – | -18.9% | +537.2% | -46.7% | +24.7% | +21.4% | +14.5% | – | |
| – | -92.6% | +896.6% | +21.1% | +150.9% | -50.2% | -28.6% | +7.7% | +12.5% | +20.6% | -7.0% | +23.8% | – | |
| – | +408.7% | -39.3% | +67.9% | +101.1% | +2.3% | -18.6% | -13.5% | +46.2% | -0.3% | -16.7% | -8.6% | – | |
| – | +136.7% | -30.5% | -3.5% | +165.7% | +23.3% | -39.6% | -9.5% | +46.9% | -13.2% | -8.3% | -0.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +66.7% | -60.0% | +418.4% | +131.5% | +37.5% | +287.9% | -88.3% | -33.3% | -40.0% | +16.7% | -14.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.